Market Entry Rewards within the Broader Incentive Landscape

News Update

Market Entry Rewards within the Broader Incentive Landscape

Date

July 17, 2018

BIOMEDICAL INNOVATION

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to “value-based” payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.

Read more in the Journal of Law, Medicine & Ethics.